Attitudes and Knowledge of Maternal-Fetal Medicine Fellows Regarding Noninvasive Prenatal Testing

Journal of Genetic Counseling

Volumn 25, Issue 1, 2016, Pages 73-78

  Swaney, Paul ^a,b   Hardisty, Emily ^b   Sayres, Lauren ^c   Wiegand, Samantha ^b   Vora, Neeta ^b  

^a NEW HANOVER REGIONAL MEDICAL CENTER   (United States)

^b UNIVERSITY OF NORTH CAROLINA   (United States)

^c DUKE UNIVERSITY   (United States)

Author keywords

Attitudes; Cell free fetal DNA; Education; Knowledge; Noninvasive prenatal testing

Indexed keywords

ADULT; ANEUPLOIDY; FEMALE; GENETIC SCREENING; HEALTH PERSONNEL ATTITUDE; HUMAN; MATERNAL SERUM SCREENING TEST; MIDDLE AGED; PRENATAL DIAGNOSIS; PROCEDURES; RISK ASSESSMENT;

ADULT; ANEUPLOIDY; ATTITUDE OF HEALTH PERSONNEL; FEMALE; GENETIC TESTING; HUMANS; MATERNAL SERUM SCREENING TESTS; MIDDLE AGED; PRENATAL DIAGNOSIS; RISK ASSESSMENT;

EID: 84955715602     PISSN: 10597700     EISSN: 15733599     Source Type: Journal    
DOI: 10.1007/s10897-015-9844-6     Document Type: Article

References (14)

1. American College of Obstetricians and Gynecologists Committee on Genetics. Committee opinion no. 545. (2012). Noninvasive prenatal testing for fetal aneuploidy. Obstetrics and Gynecology, 120(6), 1532–1534.
2. Benn, P. A., & Chapman, A. R. (2010). Ethical challenges in providing noninvasive prenatal diagnosis. Current Opinion in Obstetrics and Gynecology, 22(2), 128–134.
3. Bianchi, D. W., Platt, L. D., Goldberg, J. D., Abuhamad, A. Z., Sehnert, A. J., Rava, R. P., et al. (2012). Genome-wide fetal aneuploidy detection by maternal plasma DNA sequencing. Obstetrics and Gynecology, 119(5), 890–901.
4. Bianchi, D. W., Prosen, T., Platt, L. D., Goldberg, J. D., Abuhamad, A. Z., Rava, R. P., et al. (2013). Massively parallel sequencing of maternal plasma DNA in 113 cases of fetal nuchal cystic hygroma. Obstetrics and Gynecology, 121(5), 1057–1062.
5. Bianchi, D. W., Parker, R. L., Wentworth, J., Madankumar, R., Saffer, C., Das, A. F., et al. (2014). DNA sequencing versus standard prenatal aneuploidy screening. New England Journal of Medicine, 370(9), 799–808.
6. Brierley, K. L., Blouch, E., Cogswell, W., Homer, J. P., Pencarinha, D., Stanislaw, C. L., et al. (2012). Adverse events in cancer genetic testing: medical, ethical, legal, and financial implications. Cancer Journal, 18(4), 303–309.
7. Madan, K., & Breuning, M. H. (2014). Impact of prenatal technologies on the sex ratio in India: an overview. Genetics in Medicine, 16(6), 425–32.
8. Palomaki, G. E., Kloza, E. M., Lambert-Messerlian, G. M., Haddow, J. E., Neveux, L. M., Ehrich, M., et al. (2011). DNA sequencing of maternal plasma to detect Down syndrome: an international clinical validation study. Genetics in Medicine, 13(11), 913–920.
9. Plon, S. E., Cooper, H. P., Parks, B., Dhar, S. U., Kelly, P. A., Weinberg, A. D., et al. (2011). Genetic testing and cancer risk management recommendations by physicians for at-risk relatives. Genetics in Medicine, 13(2), 148–154.
10. Sayres, L. C., Allyse, M., Norton, M. E., & Cho, M. K. (2011). Cell-free fetal DNA testing: a pilot study of obstetric healthcare provider attitudes toward clinical implementation. Prenatal Diagnosis, 31(11), 1070–1076.
11. Selkirk, C. G., Weissman, S. M., Anderson, A., & Hulick, P. J. (2013). Physicians’ preparedness for integration of genomic and pharmacogenetic testing into practice within a major healthcare system. Genetic Testing and Molecular Biomarkers, 17(3), 219–225.
12. Vora, N. L., & O’Brien, B. M. (2014). Noninvasive prenatal testing for microdeletion syndromes and expanded trisomies: Proceed with caution. Obstetrics and Gynecology, 123(5), 1097–1099.
13. Wapner RJ, Babiarz JE, Levy B, et al. (2015) Expanding the scope of noninvasive prenatal testing: detection of fetal microdeletion syndromes. American journal of obstetrics and gynecology, 212(3): 332.e1-9
14. You, Y., Sun, Y., Li, X., Li, Y., Wei, X., Chen, F., et al. (2013). Integration of targeted sequencing and NIPT into clinical practice in a Chinese family with maple syrup urine disease. Genetics in Medicine, 16, 594–600.